← Open Payments lookup

HANG TRAN: Open Payments

NPI 1619433927 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,281 in 93 payments from 17 companies in 2025. Trend: 2023 $135 · 2024 $2,057 · 2025 $2,281

Food & beverage: $2,281
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$553
Otsuka America Pharmaceutical, Inc.12$348
ABBVIE INC.11$257
E.R. Squibb & Sons, L.L.C.5$203
Janssen Pharmaceuticals, Inc13$191
Alkermes, Inc.7$161
Supernus Pharmaceuticals, Inc.1$125
Vanda Pharmaceuticals Inc.5$125
Axsome Therapeutics, Inc.4$91
Lundbeck LLC4$68

Products named: CAPLYTA, REXULTI, VRAYLAR, COBENFY, ARISTADA, INVEGA SUSTENNA, Qelbree, FANAPT.

Industry payments across TX — which companies pay providers there.